XBIO
Xenetic Biosciences Inc
NASDAQ: XBIO · HEALTHCARE · BIOTECHNOLOGY
$3.00
-4.15% today
Updated 2026-04-29
Market cap
$6.87M
P/E ratio
—
P/S ratio
2.31x
EPS (TTM)
$-1.58
Dividend yield
—
52W range
$2 – $14
Volume
0.0M
Xenetic Biosciences Inc (XBIO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $293603.00 | $1.00M | $0.00 | $0.00 | $3.00M | $7.58M | $0.00 | $17066.00 | $436942.00 | $1.16M | $1.71M | $2.54M | $2.50M | $2.98M |
| Revenue growth (YoY) | — | +240.6% | -100.0% | — | — | +152.8% | -100.0% | — | +2460.3% | +165.6% | +47.1% | +48.8% | -1.6% | +19.0% |
| Cost of revenue | $44838.00 | $8435.00 | $0.00 | $56115.00 | $36449.00 | $156119.00 | $15827.00 | — | — | $35482.00 | $27043.00 | — | — | — |
| Gross profit | $248765.00 | $991565.00 | $0.00 | $-56115.00 | $2.96M | $7.43M | $-15827.00 | $17066.00 | $436942.00 | $1.16M | $1.71M | $2.54M | $2.50M | $2.98M |
| Gross margin | 84.7% | 99.2% | — | — | 98.8% | 97.9% | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $1.94M | $3.06M | $6.32M | $3.43M | $43.74M | $4.06M | $2.88M | $4.89M | $1.73M | $3.16M | $4.77M | $3.49M | $3.29M | $3.07M |
| SG&A | $3.45M | $6.55M | $6.60M | $6.39M | $6.69M | $6.94M | $4.39M | $4.73M | $3.40M | $3.74M | $3.65M | $3.56M | $3.42M | $2.75M |
| Operating income | $-6.34M | $-8.61M | $-12.92M | $-9.82M | $-47.43M | $-3.57M | $-7.28M | $-12.89M | $-13.94M | $-5.75M | $-6.72M | $-4.52M | $-4.20M | $-2.83M |
| Operating margin | -2160.8% | -861.3% | — | — | -1581.0% | -47.1% | — | -75511.7% | -3189.8% | -495.1% | -393.6% | -177.8% | -168.2% | -95.2% |
| EBITDA | $-5.04M | $-8.53M | $-14.21M | $-9.77M | $-53.44M | $-3.57M | $-7.26M | $-9.58M | $-4.67M | $-5.71M | $-6.69M | $-4.52M | $-4.05M | $-2.83M |
| EBITDA margin | -1716.6% | -852.7% | — | — | -1781.3% | -47.1% | — | -56111.4% | -1067.8% | -492.1% | -392.0% | -177.8% | -162.0% | -95.2% |
| EBIT | $-5.14M | $-8.58M | $-14.30M | $-9.82M | $-53.48M | $-3.59M | $-7.28M | $-9.60M | $-4.69M | $-5.75M | $-6.72M | $-4.49M | $-4.20M | — |
| Interest expense | $51739.00 | $632.00 | $4706.00 | $267000.00 | $729572.00 | $1818.00 | $24131.00 | $111804.00 | $18.36M | $101586.00 | $165555.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-6.33M | $-8.58M | $-14.31M | $-12.51M | $-54.21M | $-3.60M | $-7.30M | $-12.78M | $-10.89M | $-5.65M | $-6.55M | $-4.13M | $-3.96M | $-2.68M |
| Net income growth (YoY) | — | -35.6% | -66.8% | +12.6% | -333.4% | +93.4% | -103.1% | -75.0% | +14.7% | +48.2% | -16.1% | +36.9% | +4.2% | +32.3% |
| Profit margin | -2155.4% | -857.9% | — | — | -1806.9% | -47.4% | — | -74856.6% | -2493.1% | -486.4% | -383.9% | -162.8% | -158.4% | -90.1% |